المؤلفون: Zhenwei Tang, Minxue Shen, Xiang Chen

المصدر: Frontiers in Medicine
Frontiers in Medicine, Vol 8 (2021)

مصطلحات موضوعية: 0301 basic medicine, Medicine (General), medicine.medical_specialty, Efalizumab, Population, herpes zoster, Etanercept, 030207 dermatology & venereal diseases, 03 medical and health sciences, R5-920, 0302 clinical medicine, cohort studies, Internal medicine, Psoriasis, Ustekinumab, medicine, Adalimumab, biologics, education, education.field_of_study, business.industry, General Medicine, psoriasis, medicine.disease, Alefacept, Infliximab, infection, 030104 developmental biology, Medicine, Systematic Review, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b22b9fd841dc3738a1fab07e2cdf1ccTest
http://europepmc.org/articles/PMC8211744Test

المؤلفون: Ahmed I. Mourad, Robert Gniadecki

المصدر: Frontiers in Medicine, Vol 7 (2021)
Frontiers in Medicine

مصطلحات موضوعية: musculoskeletal diseases, 0301 basic medicine, Oncology, medicine.medical_specialty, ustekinumab, Etanercept, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, drug survival, adalimumab, Internal medicine, Psoriasis, Ustekinumab, medicine, Adalimumab, biologics, lcsh:R5-920, business.industry, Hazard ratio, psoriasis, General Medicine, medicine.disease, Infliximab, 3. Good health, meta-analysis, Ixekizumab, 030104 developmental biology, Medicine, Secukinumab, Systematic Review, infliximab, lcsh:Medicine (General), business, etanercept, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7df643f1b588c26e4883936d619a6158Test
https://doi.org/10.3389/fmed.2020.625755Test

المؤلفون: MeiQi May Liau, Hazel H Oon

المصدر: Biologics: Targets and Therapy. 13:127-132

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, Psoriasis, Ustekinumab, medicine, Adalimumab, Immunology and Allergy, Pharmacology (medical), Intensive care medicine, medicine.diagnostic_test, business.industry, Gastroenterology, medicine.disease, Infliximab, Ixekizumab, 030104 developmental biology, Guselkumab, Oncology, Therapeutic drug monitoring, Secukinumab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f0e407d840d76cbe2e6e5880f572b9d5Test
https://doi.org/10.2147/btt.s188286Test

المؤلفون: Paul J. Bryce, Danping Ding-Pfennigdorff, Matthias Herrmann, Klaus Flechsenhar, Frank O. Nestle, Peter Florian, Eckart Bartnik

المصدر: Experimental Dermatology. 29:4-14

مصطلحات موضوعية: 0301 basic medicine, Skin Absorption, Dermatology, Bioinformatics, Biochemistry, Dermatitis, Atopic, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Drug Development, In vivo, Psoriasis, Drug Discovery, Ustekinumab, medicine, Animals, Humans, Molecular Biology, Skin, Drug discovery, business.industry, Atopic dermatitis, medicine.disease, Dupilumab, Disease Models, Animal, 030104 developmental biology, Drug development, Secukinumab, Dermatologic Agents, business, Biomarkers, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf98dacd784da77d4ec6f678bb7110cfTest
https://doi.org/10.1111/exd.13942Test

المؤلفون: L. S. Kruglova, O. B. Shchukina

المصدر: Alʹmanah Kliničeskoj Mediciny, Vol 46, Iss 5, Pp 522-530 (2018)

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, pharmacologically induced psoriasis, Context (language use), paradoxical psoriasis, ustekinumab, 030207 dermatology & venereal diseases, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, inflammatory bowel disease, Psoriasis, Ustekinumab, Adalimumab, Medicine, Calcipotriol, business.industry, psoriasis, General Medicine, medicine.disease, Dermatology, Rash, Infliximab, 030104 developmental biology, tumor necrosis factor-alpha inhibitors, chemistry, Betamethasone, medicine.symptom, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec0da709187487444a9aca5fb892d441Test
https://doi.org/10.18786/2072-0505-2018-46-5-522-530Test

المؤلفون: Michael A. Loesche, Kamyar Farahi, Elizabeth A. Grice, Amanda S. Tyldsley, Samuel E. DePrimo, Marc Chevrier, Carrie Brodmerkel, Joseph Horwinski, Kristina Callis Duffin, Steven Fakharzadeh, Kimberly A. Capone, Kevin D. Smith, Andrew Blauvelt, Ernesto J. Muñoz-Elías, Bidisha Dasgupta

المصدر: Journal of Investigative Dermatology. 138:1973-1981

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Adolescent, Dermatology, Disease, Biochemistry, Pathogenesis, Young Adult, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Psoriasis, Ustekinumab, medicine, Genetic predisposition, Humans, Microbiome, Molecular Biology, Aged, Retrospective Studies, Skin, Aged, 80 and over, Innate immune system, Bacteria, Dose-Response Relationship, Drug, business.industry, Microbiota, Cell Biology, Middle Aged, medicine.disease, RNA, Bacterial, Cross-Sectional Studies, 030104 developmental biology, Immunology, Etiology, Female, Dermatologic Agents, business, Follow-Up Studies, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f00d2703afa3180542f5b6f3ad25635Test
https://doi.org/10.1016/j.jid.2018.03.1501Test

المؤلفون: Abigail Cline, Todd Wechter, Steven R. Feldman

المصدر: Therapeutics and Clinical Risk Management

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Review, 030207 dermatology & venereal diseases, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Psoriasis Area and Severity Index, IL-23, Internal medicine, Psoriasis, Ustekinumab, medicine, Adalimumab, Pharmacology (medical), biologics, General Pharmacology, Toxicology and Pharmaceutics, Adverse effect, Chemical Health and Safety, business.industry, fungi, General Medicine, medicine.disease, Clinical trial, IL-39, 030104 developmental biology, Guselkumab, monoclonal antibody, business, Safety Research, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4f8f93097822805af5810571aec35ffTest
http://europepmc.org/articles/PMC6110646Test

المؤلفون: Makoto Sugaya

المصدر: International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 4, p 1314 (2020)

مصطلحات موضوعية: 0301 basic medicine, Keratinocytes, wound healing, Disease, Review, Catalysis, ustekinumab, Dermatitis, Atopic, Inorganic Chemistry, Interleukin 22, lcsh:Chemistry, 030207 dermatology & venereal diseases, 03 medical and health sciences, antimicrobial peptides, 0302 clinical medicine, IL-26, Psoriasis, Ustekinumab, medicine, IL-22, Humans, Physical and Theoretical Chemistry, Molecular Biology, lcsh:QH301-705.5, Spectroscopy, Skin, Interleukin-13, business.industry, Multiple sclerosis, Interleukins, Organic Chemistry, Interleukin-17, subtypes of atopic dermatitis, General Medicine, Atopic dermatitis, medicine.disease, Computer Science Applications, 030104 developmental biology, lcsh:Biology (General), lcsh:QD1-999, Rheumatoid arthritis, Immunology, Cytokines, Th17 Cells, Interleukin-4, business, Wound healing, medicine.drug, Antimicrobial Cationic Peptides

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ff222ca76e964af4fa0b3a0ab24919dTest
http://europepmc.org/articles/PMC7072946Test

المؤلفون: Marieke J H Coenen, Jo Lambert, Külli Kingo, J.M.P.A. van den Reek, N. Heddes, Mark S. Talamonti, E. Meulewaeter, Marco Galluzzo, E.M.G.J. de Jong, Marina Hakobjan, L.J. van Vugt, Tanel Traks

المصدر: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
JEADV : Journal of the European Academy of Dermatology and Venereology, 34, 1, pp. 112-118
JEADV : Journal of the European Academy of Dermatology and Venereology, 34, 112-118

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cohort Studies, 030207 dermatology & venereal diseases, 0302 clinical medicine, Untranslated Regions, Medicine and Health Sciences, Medicine, RISK, DRUG-SURVIVAL, Interleukin-17, ASSOCIATION, Middle Aged, Europe, Treatment Outcome, Infectious Diseases, Cohort, Female, medicine.drug, Adult, medicine.medical_specialty, USTEKINUMAB, Dermatology, Antibodies, Monoclonal, Humanized, Open Reading Frames, 03 medical and health sciences, Settore MED/35, Psoriasis, Internal medicine, Genetic variation, Ustekinumab, Humans, TO-SEVERE PSORIASIS, Genotyping, POLYMORPHISMS, METAANALYSIS, Neurodevelopmental disorders Donders Center for Medical Neuroscience [Radboudumc 7], business.industry, Genetic Variation, IN-VITRO, medicine.disease, Pharmacogenomic Testing, BODY-MASS INDEX, Ixekizumab, 030104 developmental biology, Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5], Secukinumab, Dermatologic Agents, ANTI-TNF TREATMENT, business, Pharmacogenetics

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0435c9252565cad8c367a74f054b03b5Test
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/218238Test

المؤلفون: Richard B. Warren, A. Al‐Janabi, A.C. Foulkes, Catherine H. Smith, Cem Griffiths, K.J. Mason

المصدر: Journal of the European Academy of Dermatology and Venereology : JEADVReferences. 34(7)

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Eczema, Dermatology, Etanercept, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Psoriasis, Ustekinumab, medicine, Adalimumab, Humans, Biological Products, business.industry, Antibodies, Monoclonal, medicine.disease, Infliximab, Ixekizumab, 030104 developmental biology, Infectious Diseases, Phenotype, Secukinumab, Apremilast, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88da706eb796f4db7db19b1c5fae6c67Test
https://pubmed.ncbi.nlm.nih.gov/31997406Test